Selecta Biosciences, Inc.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
0/10
|
0 | 48.72 | -100% | -0.3208 | -100% |
| P/S |
|
0.1417 | 33.75 | -99.58% |
|
|
| P/BV |
|
-0.0084 | 4.82 | -100.17% |
|
|
| P/FCF |
|
0 | 61 | -100% |
|
|
| Ev/Ebitda |
|
0.7336 | -22.17 | -103.31% |
|
|
| Ev/S |
|
-2.39 | 22.56 | -110.62% |
|
|
| Ev/FCF |
|
1.21 | 68.75 | -98.24% |
|
|
| E/P |
|
0 | 0.0178 | -100% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
0/10
|
-326.42 | 4.98 | -6658.63% | -404.07 | -19.22% |
| ROE |
|
49.91 | 9.61 | 419.3% |
|
|
| ROA |
|
-72.02 | 0.3443 | -21021.51% |
|
|
| ROIC |
|
0 | 7.63 | -100% |
|
|
| ROS |
|
-844.91 | -25.17 | 3256.81% |
|
|
| ROCE |
|
19.64 | 15.35 | 27.92% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
10/10
|
-0.1291 | -3.68 | -96.49% | -1.47 | -91.24% |
| Nеt Debt/Ebitda |
|
0.777 | -3.44 | -122.61% |
|
|
| Debt/Ratio |
|
0.0359 | 0.1985 | -81.91% |
|
|
| Debt/Equity |
|
0 | 1.51 | -100% |
|
|
| Debt/Net Income |
|
-0.0499 | 10.32 | -100.48% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
0/10
|
0 | 0.5473 | -100% | 0 | 0% |
| Number of years of dividend growth |
|
0 | 0.7368 | -100% | ||
| DSI |
|
0 | 0.2237 | -100% |
|
|
| Average dividend growth |
|
0 | 0.9889 | -100% |
|
|
| Average percentage for 5 years |
|
0 | 0.4952 | -100% |
|
|
| Average percentage for payments |
|
0 | 43.56 | -100% |
|
|
| Difference from average difference in sector |
|
-0.5473 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
10/10
|
288.12 | -56.89 | -606.45% | ||
| Growth impulse Ebitda in 5 years |
|
336.92 | -54.68 | -716.17% | ||
| Growth impulse Net Income in 5 years |
|
296.59 | -58.33 | -608.47% | ||
| Growth impulse FCF in 5 years |
|
-0.2583 | -49.48 | -99.48% | ||
| Growth impulse EPS in 5 years |
|
6527.34 | -32.41 | -20239.9% |
IP Score
5.09/10
